自然主义者对健康衰老的看法发生了变化,对轻微的认知障碍进行了大赦
Anisha Khosla1,2, Jordana S Wynn3, Arber Kacollja4
1Rotman Research Institute, Baycrest Academy for Research and Education, Toronto, Ontario, Canada.
Hippocampus
|September 30, 2025
概括
老龄化中的记忆力下降和缓解记忆的轻度认知障碍 (aMCI) 改变了视觉探索. 在aMCI和老年人中减少的探索和改变的眼睛运动表明海马和中间叶 (HC/MTL) 对观看模式的影响.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 眼科医生 眼科 眼科
背景情况:
- 视觉探索是以先前的经验和记忆为指导.
- 健康的衰老和缓解记忆的轻度认知障碍 (aMCI) 破坏了记忆引导的观看.
- 海马和中间叶 (HC/MTL) 结构对于记忆和认知控制至关重要.
研究的目的:
- 与年轻人相比,研究老年人和aMCI患者自然观看行为的变化.
- 为了确定HC/MTL下降是否影响时刻视觉探索.
- 探索认知状态和观看模式之间的关系.
主要方法:
- 在自然观看过程中对眼动数据的多变量分析.
- 三组观看模式的比较:年轻人,健康的老年人和患有MCI的个人.
- 视觉与整体认知状态和记忆子测试分数的相关性.
主要成果:
- 年轻的成年人表现出更大的萨卡德幅度和探索区域.
- 患有aMCI的个体表现出相反的模式,探测面积较小.
- 健康的老年人眼睛的凝视时间较短,观看与认知状态相关.
- 较低的记忆分数与减少探索,更少的固定和更低的度有关,类似于aMCI模式.
结论:
- 视觉探索模式在健康衰老和aMCI中发生显著变化.
- HC/MTL完整性影响主动视力,其下降导致不那么探索性观看.
- 认知功能,特别是记忆,对自然主义的视觉探索进行自上而下的控制.
相关概念视频
Cognitive Development During Adulthood
780
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
780
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia
523
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
523
Naturalistic Observations
17.0K
If you want to understand how behavior occurs, one of the best ways to gain information is to simply observe the behavior in its natural context. However, people might change their behavior in unexpected ways if they know they are being observed. How do researchers obtain accurate information when people tend to hide their natural behavior? As an example, imagine that your professor asks everyone in your class to raise their hand if they always wash their hands after using the restroom. Chances...
17.0K
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
560
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
560


